Effects of mianserin in depression in elderly patients
- 1 January 1980
- journal article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 6 (sup7), 139-143
- https://doi.org/10.1185/03007998009114814
Abstract
SummaryEleven elderly in-patients {mean age 70 years, range 57 to 82 years) diagnosed as having an organic depressive disorder were treated with mianserin for 28 days. Mean dosage initially was 28 mg per day and this was increased gradually to 43 mg per day during the study period. Assessments of response to treatment, using the Hamilton Rating Scale for Depression and the Clinical Global Impressions scale, showed that only 2 patients failed to improve and this was reflected in the marked reduction from baseline values in the mean Hamilton rating scores. Few side-effects or significant changes in blood chemical or haematological parameters were reported. The results suggest, therefore, that mianserin is an effective and well-tolerated form of anti-depressive therapy in the elderly.Keywords
This publication has 6 references indexed in Scilit:
- A double‐blind multicentre trial comparing mianserin with imipramine.British Journal of Clinical Pharmacology, 1978
- Three Double-Blind Comparative Trials of Mianserine (ORG GB 94) and Amitriptyline in the Treatment of Depressive IllnessPharmacopsychiatry, 1977
- Mianserin Hydrochloride: A Novel AntidepressantThe British Journal of Psychiatry, 1976
- Mianserin versus AmitriptylineInternational Pharmacopsychiatry, 1976
- A Comparative Clinical Trial of Org GB 94 and Imipramine in the Treatment of Depression in General PracticeJournal of International Medical Research, 1975